Opportunity timeline

PostedOct 26, 2026
DeadlineNov 2, 2026

In plain English

The Michigan Department of Health and Human Services is seeking second-tier newborn screening tests on dried blood spots, along with interpretation of results. The tests cover several conditions, including congenital adrenal hyperplasia, metabolic disorders, Pompe disease, and X-linked adrenoleukodystrophy. The department says Mayo Medical Laboratories is the only provider able to meet its testing and interpretation needs.

About this opportunity

The Michigan Department of Health and Human Services Bureau of Laboratories (MDHHS-BOL) intends to contract with Mayo Medical Laboratories for second-tier testing of dried blood spots as well as the interpretation of the results as part of newborn screening. Testing must be for specific analytes, including: 17-hydroxyprogesterone, androstenedione, cortisol, 11-deoxycortisol and 21-deoxycortisol for congenital adrenal hyperplasia (CA), Homocysteine (total), methylmalonic acid and methylcitric acid for propionic acidemia, methylmalonic acidemia, homocystinuria, (PA/MMA/HCU), Heparan sulfate and dermatan sulfate for mucopolysaccharidiosis types I, II, III, IV (MPS I, II, III, IV), Creatine,…

Time remaining

Closes Nov 2, 2026

04Days
:
14Hours
:
45Min
:
11Sec

Related Opportunities

Bid details are gathered and summarized automatically. Please verify details at the original source.

Ref No.

BS-8F969C